What is Quest Diagnostics's share buybacks?

Quest Diagnostics (DGX) reported share buybacks of $300M in Q4 2025.

How has Quest Diagnostics's share buybacks changed year-over-year?

Quest Diagnostics's share buybacks increased by 98.7% year-over-year, from $151M to $300M.

What is the long-term trend for Quest Diagnostics's share buybacks?

Over 2 years (2021 to 2023), Quest Diagnostics's share buybacks has grown at a -64.6% compound annual growth rate (CAGR), from $2.2B to $275M.

What does share buybacks mean?

Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Quest Diagnostics DGX Share Buybacks

Share Buybacks at other companies

Labcorp HoldingsLH

-$353.8M-277%

Opko HealthOPK

$13.02M-28.7%

Fulgent Genetics, Inc.FLGT

$40.08M+362%

Agilent TechnologiesA

$65M-60.6%

Bio-Rad LaboratoriesBIO

$47.8M-53.1%

RevvityRVTY

$86.5M-43.7%

Other financials

Income statement

See full

Revenue$3.0B+10.2%

Gross profit$1.0B+8.9%

Operating income$459.0M+4.8%

Net income$320.0M+13.5%

EPS (diluted)$2.84+15.0%

Balance sheet

See full

Cash & equivalents$626.0M+96.2%

Total debt$6.4B0.0%

Total equity$7.5B+4.0%

Total assets$16.9B+6.1%

Cash flow

See full

Operating cash flow$597.0M+9.7%

CapEx$138.0M+27.8%

Free cash flow$459.0M+5.3%

Valuation

See full

Market cap$26.04B+38.7%

Enterprise value$31.8B+28.0%

P/E24.5×+4.8×

P/S2.3×+0.5×

Profitability

See full

Gross margin33.1%+0.1pp

Operating margin14.1%+0.1pp

Net margin9.2%+0.2pp

FCF margin11.7%0.0pp

Returns & leverage

See full

Return on equity14.4%+0.7pp

Debt / equity0.8×0.0×

Current ratio1.6×+0.5×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Quest Diagnostics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Quest Diagnostics's share buybacks?: Quest Diagnostics (DGX) reported share buybacks of $300M in Q4 2025.
How has Quest Diagnostics's share buybacks changed year-over-year?: Quest Diagnostics's share buybacks increased by 98.7% year-over-year, from $151M to $300M.
What is the long-term trend for Quest Diagnostics's share buybacks?: Over 2 years (2021 to 2023), Quest Diagnostics's share buybacks has grown at a -64.6% compound annual growth rate (CAGR), from $2.2B to $275M.
What does share buybacks mean?: Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.